Literature DB >> 10063880

Primary leiomyosarcoma of bone.

M Sundaram1, I Akduman, L M White, D J McDonald, R Kandel, C Janney.   

Abstract

OBJECTIVE: This study describes radiographic and MR imaging features of primary leiomyosarcoma of bone. SUBJECTS AND METHODS: Twelve patients (five men and seven women, 39-79 years old) who were treated at two oncology centers for primary leiomyosarcoma of bone involving the femurs, tibia, ilium, and inferior pubic ramus were studied. None of the patients had preexisting disease or disease elsewhere at the time of diagnosis. Pathologic diagnosis was obtained in all patients.
RESULTS: Radiographs of all patients showed a matrix that was exclusively osteolytic. In long bones (seven patients), the tumor had an average length of 11 cm (range, 7-17 cm) and revealed an elongated configuration. In the pelvis (five patients), the average length of the tumor was 10 cm (range, 4-15 cm). MR imaging confirmed an intramedullary lesion in all patients, with extension into the soft tissues in eight patients and no identifiable soft-tissue mass in the remaining four patients. Four of the five pelvic tumors had a prominent soft-tissue mass, whereas only four of the seven long bone lesions revealed a soft-tissue mass that was, in all instances, small. The tumor was hypointense on T1-weighted images and showed heterogeneous signal intensity on T2-weighted conventional and fast spin-echo sequences. We saw low signal intensity (short T2) in eight patients and homogeneous hyperintense signal intensity in one patient. In the remaining three patients, T2-weighted spin-echo sequences obtained with fat saturation showed high signal intensity (long T2) in the tumors.
CONCLUSION: Primary leiomyosarcoma of bone is a rare tumor that on radiography reveals no matrix and on MR imaging reveals areas of T2 shortening in relation to fat on conventional and fast spin-echo sequences.

Entities:  

Mesh:

Year:  1999        PMID: 10063880     DOI: 10.2214/ajr.172.3.10063880

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  8 in total

Review 1.  The rare primary bone sarcomas: imaging-pathological correlation.

Authors:  Rupert Berkeley; Vanghelita Andrei; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2021-01-07       Impact factor: 2.199

2.  Subperiosteal leiomyosarcoma of the tibia.

Authors:  J A Narváez; E De Lama; F Portabella; R Ortega; E Condom
Journal:  Skeletal Radiol       Date:  2004-10-02       Impact factor: 2.199

3.  Imaging findings, prevalence and outcome of de novo and secondary malignant fibrous histiocytoma of bone.

Authors:  Monica C Koplas; Robert A Lefkowitz; Thomas W Bauer; Michael J Joyce; Hakan Ilaslan; Jonathan Landa; Murali Sundaram
Journal:  Skeletal Radiol       Date:  2009-11-20       Impact factor: 2.199

4.  A primary leiomyosarcoma of bone containing pseudoepithelial plexiform elements.

Authors:  A Rigopoulou; M Vlychou; S J Ostlere; C L M H Gibbons; N A Athanasou
Journal:  Skeletal Radiol       Date:  2007-05-05       Impact factor: 2.199

5.  Distal ulna leiomyosarcoma treated with custom polymethylmethacrylate prosthesis with a 4-year follow-up.

Authors:  Jose Arturo Pacheco-Nuñez; Joseph E Sheppard; Andrew P Mahoney
Journal:  Hand (N Y)       Date:  2015-09

Review 6.  Leiomyosarcoma of the distal femur in a patient with a history of bilateral retinoblastoma: a case report and review of the literature.

Authors:  R S Ryan; R Gee; J X O'Connell; A C Harris; P L Munk
Journal:  Skeletal Radiol       Date:  2003-05-21       Impact factor: 2.199

7.  MRI, MDCT features, and clinical outcome of extremity leiomyosarcomas: experience in 47 patients.

Authors:  Robert W Gordon; Sree Harsha Tirumani; Vikram Kurra; Atul B Shinagare; Jyothi P Jagannathan; Jason L Hornick; Nikhil H Ramaiya
Journal:  Skeletal Radiol       Date:  2014-02-05       Impact factor: 2.199

8.  Primary leiomyosarcoma of the distal fibula: A case report and review of the literature.

Authors:  Marwan Hanafy; Martin Schwonzen; Cornelius Kuhnen; Bernhard Schley; Axel Wilke
Journal:  Orthop Rev (Pavia)       Date:  2018-02-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.